covid-19 pandemic information patient

Q&A with IQVIA: digital transformation in a post-Covid-19 world

Reading now: 508
www.pharmaceutical-technology.com

Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.The pharma industry – and clinical trials in particular – have been significantly disrupted by the Covid-19 pandemic.

For example, lockdowns and social distancing have made it all but impossible for many ill patients to visit their trial sites for monitoring and medication.

It has also been challenging for the industry to retain communication channels with healthcare professionals (HCPs) and patients, both during trials and commercialisation of products.

Issues with the stability of global supply chains has further complicated the industry’s ability to continue its clinical trials and selling its product on the market.

Read more on pharmaceutical-technology.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA